Ranking Profile - Glaukos Corp

Introduction

Glaukos Corp (Glaukos) is an ophthalmic medical device company that research and develops micro technologies to improve glaucoma therapy. The company develops injectable micro-scale therapies to address the complete range of glaucoma disease states and progression. It provides products such as microstent devices to treat glaucoma such as iStent trabecular micro-bypass stent for the treatment of mild- tomoderate open-angle glaucoma. Glaukos’ iStent is used in conjunction with cataract surgery. Glauko’s iStent improves outflow by creating a patent bypass between the anterior chamber and Schlemm’s canal. The company markets its products through a network of distributors in Germany, Canada, the UK, Australia, Brazil and Japan, among others. Glaukos is headquartered in San Clemente, California, the US.

Company info

Country (HQ): United States
Sector: Medical Equipment
Market Cap (US$ m): 2,877
Revenue (US$ m): 283 (2022)

Innovation ranking

438

Innovation score

Closest peers in the Medical Equipment sector

Innovation Ranking

Company
Headquarters
Sector

Medtronic Plc

Ireland

Medical Equipment

Boston Scientific Corp

United States

Medical Equipment

Glaukos Corp

United States

Medical Equipment

Savara Inc

United States

Medical Equipment

Aethlon Medical Inc

United States

Medical Equipment

Are you ranked? Get the Innovation Ranking Report

  • Company Ranking Report
    • If your company is ranked you can get more detailed information about your ranking through the Innovation Ranking Report
    • Full company scorecard across the 3 pillars and 19 data indicators that make up the ranking score
    • Contextualised information on the company's standing in relation to peers
    • Key takeaways on the company's position in its sector, country and its standing in relation to key industry themes
    • Tips on how to use your ranking to tell a unique and compelling story in your marketing, benchmarking and hiring processes
  • Rosettes
  • Certificate of Achievement
  • Press release
Screenshot of Deal Makers